Aware Super Pty LTD As Trustee Of Aware Super Gilead Sciences, Inc. Transaction History
Aware Super Pty LTD As Trustee Of Aware Super
- $6.82 Trillion
- Q2 2025
A detailed history of Aware Super Pty LTD As Trustee Of Aware Super transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Aware Super Pty LTD As Trustee Of Aware Super holds 122,261 shares of GILD stock, worth $13.5 Million. This represents 0.2% of its overall portfolio holdings.
Number of Shares
122,261
Previous 44,007
177.82%
Holding current value
$13.5 Million
Previous $4.93 Billion
174.9%
% of portfolio
0.2%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding GILD
# of Institutions
2,295Shares Held
1BCall Options Held
9.59MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...